Feds say Mylan overcharged for EpiPen - The Boston Globe

Feds say Mylan overcharged for EpiPen - The Boston Globe: "Feds say Mylan overcharged for EpiPen

Mylan NV for years overcharged the US Medicaid health program for its EpiPen shot, the government said Wednesday. From 2011 to 2015, the joint state-federal program for the poor spent about $797 million on EpiPens, the Centers for Medicare and Medicaid Services, said Wednesday. That included rebates of about 13 percent. But the United States should have been getting a larger discount of at least 23.1 percent. While the agency didn’t say exactly how much Mylan had overcharged, the amount could be substantial. Under law, companies are required to give Medicaid back any price increases they take on brand drugs above the rate of inflation, in addition to the 23.1 percent discount. Mylan, after acquiring the drug in 2007, has raised the price of EpiPen by about sixfold, to over $600 for a package of two. The government has in the past “expressly told Mylan that the product is incorrectly classified,” CMS said in the letter, which came in response to an inquiry by Congress.
— BLOOMBERG NEWS"



'via Blog this'